Cargando…

Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia

SIMPLE SUMMARY: Recent genomic studies have identified chromatin-spliceosome (CS)-acute myeloid leukemia (AML) as a new subgroup of AML. CS-AML is defined by several mutations that perturb epigenetic regulation, such as those affecting splicing factors, cohesin components, transcription factors, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochi, Yotaro, Ogawa, Seishi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999050/ https://www.ncbi.nlm.nih.gov/pubmed/33799787 http://dx.doi.org/10.3390/cancers13061232

Ejemplares similares

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
por: Taylor, Justin, et al.
Publicado: (2019)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
por: Caprioli, Chiara, et al.
Publicado: (2020)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

Targeting Chromatin Regulation in Acute Myeloid Leukemia
por: Richardson, Simon E., et al.
Publicado: (2021)

Modulation of splicing catalysis for therapeutic targeting of leukemias with spliceosomal mutations
por: Lee, Stanley Chun-Wei, et al.
Publicado: (2016)

Mutations in spliceosomal proteins and retina degeneration
por: Růžičková, Šárka, et al.
Publicado: (2016)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
por: Zarka, Jabra, et al.
Publicado: (2020)

Acute Myeloid Leukemia Mutations: Therapeutic Implications
por: Papayannidis, Cristina, et al.
Publicado: (2019)

Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
por: Daido, Yusuke, et al.
Publicado: (2023)

The impact of spliceosome mutations in MDS
por: Boultwood, Jacqueline, et al.
Publicado: (2019)

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
por: Shiozawa, Yusuke, et al.
Publicado: (2018)

Current findings for recurring mutations in acute myeloid leukemia
por: Takahashi, Shinichiro
Publicado: (2011)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
por: El Fakih, Riad, et al.
Publicado: (2018)

Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia
por: Panuzzo, Cristina, et al.
Publicado: (2020)

Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
por: Lu, Rui, et al.
Publicado: (2017)

IDH1/2 mutations in acute myeloid leukemia
por: Byun, Ja Min, et al.
Publicado: (2022)

TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
por: Testa, Ugo, et al.
Publicado: (2023)

Spliceosome assembly and regulation: insights from analysis of highly reduced spliceosomes
por: Black, Corbin S., et al.
Publicado: (2023)

Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia
por: Mohanty, Sagarajit, et al.
Publicado: (2021)

Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2020)

Clinical implications of recurrent gene mutations in acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation
por: Imataki, Osamu, et al.
Publicado: (2020)

Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
por: Croucher, Peter J P, et al.
Publicado: (2023)

The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia
por: Lebecque, Benjamin, et al.
Publicado: (2022)

Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
por: Wang, Mengning, et al.
Publicado: (2017)

The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2013)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
por: Cloobs-Venezia, Maximiliano, et al.
Publicado: (2022)

TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
por: George, Binsah, et al.
Publicado: (2021)

Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
por: Arai, Hironori, et al.
Publicado: (2022)

TP53 Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
por: Shin, Dong-Yeop
Publicado: (2023)

Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
por: Inoue, Daichi, et al.
Publicado: (2016)

Structure of spliceosomal ribonucleoproteins
por: Krummel, Daniel Aaron Pomeranz, et al.
Publicado: (2010)

t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming
por: Kellaway, Sophie, et al.
Publicado: (2020)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

The spliceosome as target for anticancer treatment
por: van Alphen, R J, et al.
Publicado: (2009)

Origin and evolution of spliceosomal introns
por: Rogozin, Igor B, et al.
Publicado: (2012)

Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia
por: Burchert, Andreas
Publicado: (2021)

Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia
por: Wang, Shujuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mlile523q64kco0ul6bc4k3uj